New Edge Advisors, LLC Bio Rad Laboratories, Inc. Transaction History
New Edge Advisors, LLC
- $11.2 Billion
- Q1 2024
A detailed history of New Edge Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 531 shares of BIO stock, worth $148,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531
Previous 686
22.59%
Holding current value
$148,812
Previous $221,000
17.19%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BIO
# of Institutions
489Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$679 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$415 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$321 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$245 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$144 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.9B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...